The Bloomberg BNA Intellectual Property Blog is the home of the "Do You Copy?" podcast and offers links to selected articles by the BNA IP team, which is accessible to both subscribers and non-subscribers as well as commentary and analysis exclusive to this blog.
Friday, April 12, 2013
by Anandashankar Mazumdar
Podcast (stream or download):
In this week's episode of "Do You Copy?," Ananda and Tony discuss the big picture when it comes to Novartis's failure to get a patent on its improved cancer drug. And then it's on to two decisions in which copyrights are pitted against service providers. In one case, Tony revisits an old rant against the U.S. Court of Appeals for the Second Circuit when talking about the latest decision in the Aereo case. And Ananda talks about the downfall of ReDigi's attempt to sell second-hand digitized music.
You must Sign In or Register to post a comment.
Ten Things You Need to Know About Social Media and Intellectual Property
If High Court Nixes Myriad Gene Patent, Look to Decades of Uncertainty, Panel Says
Following Remand, District Court Again Says YouTube Protected by DMCA's Safe Harbors
'Do You Copy?' Podcast, Episode 56, May 3, 2013
Former Franchisee's Continued Use of Marks After Agreement's Termination Was Infringing